8 GLP-1 Weight Loss Programs Worth Comparing Before You Commit

Most people shopping this category assume all telehealth GLP-1 providers are basically the same. They are not. Prices for identical medications vary by $200 a month or more across these platforms, pharmacy transparency ranges from none to detailed lot tracking, and the post-FDA-warning-letter shakeout of early 2026 left some brands scrambling to switch medication types mid-subscription. The differences matter.

Quick Comparison

Provider	Starting Price (meds)	Medication Type	Ships All 50 States	Physician Review	Pharmacy Named?
HealthRX	Sema ~$99/mo, Tirz ~$149/mo	Compounded	Yes	~24 hours	Yes (Manifest, SC)
FormBlends	Sema ~$299/vial, Tirz ~$349/vial	Compounded	47 states	Physician-supervised	Yes (503A registered)
Mochi Health	Sema ~$99/mo, Tirz ~$199/mo	Compounded	Varies	Board-certified obesity MDs	Varies
Hims & Hers	Wegovy ~$299/mo, Zepbound ~$399/mo	Branded	Yes	Async	Not disclosed
Ro Body	~$39 first month + meds	Branded (insurance)	Yes	Prior-auth team	Not disclosed
Henry Meds	~$179-249 month one	Compounded	Varies	Lighter monitoring	Not disclosed
PlushCare	~$19.99/mo + branded meds	Branded	Yes	Same-day visits	N/A (pharmacy Rx)
Found	~$99/mo + meds	Both	Yes	Coaching included	N/A

1. HealthRX

The strongest case for HealthRX is straightforward: it starts at $99 a month for compounded semaglutide and $149 for compounded tirzepatide, ships free overnight to all fifty states, and it names its pharmacy outright. That combination is not common in this space.

Medications come from Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot tracking from production to delivery. LegitScript certification (number 50087439) is publicly verifiable. An online health assessment goes to a US board-certified physician, and review typically happens within about 24 hours. Once approved, medication ships overnight.

The clinical numbers HealthRX references come from published trials, not internal claims. SURMOUNT-1 data showed tirzepatide associated with roughly 21% body weight reduction over 72 weeks; the STEP 1 trial showed semaglutide at approximately 15% over 68 weeks. These are trial populations, not guarantees.

Compounded medications are not FDA-approved finished drugs. That caveat applies across this entire category and is worth understanding before choosing any provider. But for someone who wants a low cash price, national overnight shipping, and a pharmacy they can actually look up, HealthRX makes a clear, specific argument for itself.

Best for: Uninsured or cash-pay patients who want the lowest available entry price and same-night shipping without sacrificing pharmacy accountability.

2. FormBlends

FormBlends occupies a different corner of this market. The cash pricing runs higher than HealthRX’s, around $299 per vial of semaglutide and $349 for tirzepatide, but the brand publishes per-product purity testing in unusual detail. HPLC purity percentages, mass spec identity confirmation, and endotoxin sterility results are listed per batch. That level of documentation is genuinely rare among telehealth compounders.

The platform also offers a wide peptide catalog beyond GLP-1s, covering recovery, longevity, and cognitive compounds under the same physician-supervised model. Most GLP-1 telehealth providers stop at weight-loss medications entirely. Shipping covers 47 states, not all 50.

If you want a second layer of chemical verification or plan to use a single provider for multiple peptide protocols, FormBlends justifies its price premium. If weight loss at the lowest available cost is the only goal, HealthRX wins on value.

Best for: Patients who prioritize published lab verification or want GLP-1s alongside a broader peptide program from one clinical provider.

3. Mochi Health

Mochi’s differentiator is clinical staffing. Board-certified obesity-medicine physicians run the prescribing side, which puts it a step above purely async platforms for patients with complicated histories. Compounded semaglutide runs around $99 a month; tirzepatide sits closer to $199. Monitoring is more involved than Henry Meds, which can be either reassuring or inconvenient depending on what you want.

4. Hims & Hers

After the March 2026 Novo Nordisk settlement, Hims & Hers exited compounded GLP-1s and shifted to branded medications. Wegovy runs roughly $299 a month through the platform, Zepbound around $399. With insurance and a manufacturer savings card, some users pay as little as nothing. The brand’s size means name recognition and slick UX. The tradeoff is that cash-pay pricing is among the highest on this list.

5. Ro Body

Ro’s first month is around $39, but that is a platform fee. Branded medications bill separately, and the real differentiator is the prior-authorization team Ro offers to help patients get insurance to cover drugs like Wegovy. For someone with insurance who finds prior-auth paperwork daunting, that service has real practical value.

6. Henry Meds

Henry Meds is a cash-pay compounded option with notably fast shipping, typically 24 to 72 hours. First-month costs generally fall somewhere between $179 and $249. Monitoring is lighter than Mochi or HealthRX’s physician review model. Fine for someone who just wants quick access and a lower barrier to start.

7. PlushCare

PlushCare’s $19.99 monthly membership opens access to same-day telehealth visits across a wide range of conditions, not only weight loss. GLP-1 prescriptions go to standard retail pharmacies, so the cost of branded meds applies on top. It fits best if you already have good insurance coverage for Wegovy or Zepbound and mainly need a quick prescribing visit.

8. Found

Found charges roughly $99 a month for the platform and adds medication costs on top. The program pairs GLP-1 prescriptions with behavioral coaching, which some patients find motivating and others find redundant if they have outside support. Both branded and compounded options are available depending on clinical assessment.

A Note on the 2026 Regulatory Environment

The FDA sent warning letters to more than 30 compounding telehealth firms early in 2026. The March Novo settlement changed how several brands could offer compounded semaglutide. Oral orforglipron became available through LillyDirect around April 2026 at approximately $149 a month. This category is still changing fast, and any pricing or availability listed here reflects conditions as of mid-2026.

Common Questions

Is compounded semaglutide from HealthRX or Henry Meds the same drug as Ozempic or Wegovy?

No. Compounded semaglutide contains the same active molecule but is not manufactured by Novo Nordisk and is not an FDA-approved finished drug. It is produced by a licensed compounding pharmacy under USP-797 standards. Quality controls vary by pharmacy, which is why named pharmacies with published lot tracking matter when choosing a provider.

After the March 2026 Novo Nordisk settlement, which providers on this list can still offer compounded semaglutide?

The settlement affected how platforms marketed and sourced compounded semaglutide. Hims & Hers exited compounded GLP-1s entirely and moved to branded options. Providers like HealthRX, Mochi Health, and Henry Meds continued offering compounded formulations as of mid-2026, though availability can shift. Check each platform directly before assuming a specific medication type is still on offer.

If I have insurance, does it make more sense to go with Ro Body or PlushCare instead of a cash-pay compounded program?

Possibly, yes. Ro’s prior-authorization support is a concrete advantage if your insurer covers Wegovy or Zepbound and you find that paperwork difficult to manage alone. PlushCare works well if you already have strong coverage and just need a prescribing visit. Cash-pay compounded programs like HealthRX at $99 a month beat out-of-pocket branded costs for most people without insurance.

What does FormBlends’ batch testing actually show, and why does it matter compared to providers that don’t publish that data?

FormBlends publishes HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results per batch. That documentation lets a patient or their physician verify that what is in the vial matches the label. Providers that do not publish this data are not necessarily cutting corners, but there is no independent way to confirm purity without it.

Can I switch from one provider to another mid-program if my medication type changes or pricing goes up?

Yes, practically speaking. These are month-to-month subscriptions for most providers on this list. You would need a new clinical intake assessment at the new platform, and some require a fresh physician review before prescribing. Dose continuity is worth discussing with whichever physician reviews your new intake, since titration schedules differ across providers.

Sources

• FDA compounding warning letters, FDA.gov (2026 enforcement actions)
• SURMOUNT-1 trial (tirzepatide), *New England Journal of Medicine*, vol. 387, 2022
• STEP 1 trial (semaglutide), *New England Journal of Medicine*, vol. 384, 2021
• LegitScript pharmacy certification database, LegitScript.com
• Novo Nordisk settlement reporting, *Reuters* and *STAT News*, March 2026
• LillyDirect orforglipron announcement, Eli Lilly press release, April 2026